首页 / 院系成果 / 成果详情页

One Dose versus Three Weekly Doses of Benzathine Penicillin G for Patients Co-Infected with HIV and Early Syphilis: A Multicenter, Prospective Observational Study  期刊论文  

  • 编号:
    89e0af1c-e92c-4b7d-a0a3-8dcbd5215853
  • 作者:
    Yang, ChiaJui[1];Lee, NanYao[2];Chen, TunChieh[3,4];Lin, YuHui[5];Liang, ShiouHaur[6];Lu, PoLiang[3];Huang, WenChi[7];Tang, HungJen[8];Lee, ChenHsiang[7];Lin, HsiHsun[6];Chen, YenHsu[3]Ko, WenChien[2];Hung, ChienChing[9,10,11,12]
  • 语种:
    英文
  • 期刊:
    PLOS ONE ISSN:1932-6203 2014 年 9 卷 10 期 ; OCT 6
  • 疾病分类:
    梅毒、艾滋病其它感染性疾病
  • 摘要:

    Background: One dose of benzathine penicillin G (BPG) has been recommended for HIV-infected patients with early syphilis (primary, secondary, and early latent syphilis) in the sexually transmitted diseases treatment guidelines, but clinical data to support such a recommendation are limited. Methods: We prospectively observed the serological response to 1 or 3 weekly doses of BPG in HIV-infected adults who sought treatment of early syphilis at 8 hospitals around Taiwan. Rapid plasma reagin (RPR) titers were followed every 3-6 months after treatment. The serological response was defined as a 4-fold or greater decline in RPR titers at 12 months of treatment. The missing values were treated by following the last-observed-carried-forward principle. We hypothesized that 1 dose was non-inferior to 3 weekly doses of BPG with the non-inferiority margin for the difference of serological response set to 10%. Results: Between 2007 and 2012, 573 patients completed at least 12 months of follow-up: 295 (51.5%) receiving 1 dose of BPG (1-dose group) and 278 (48.5%) 3 doses (3-dose group). Overall, 198 patients (67.1%; 95% confidence interval [CI], 61.4-72.5%) in the 1-dose group achieved serological response at 12 months, as did 208 patients (74.8%; 95% CI, 69.3-79.8%) in the 3-dose group (one-sided 95% CI of the difference, 15.1%). In the multivariate analysis, secondary syphilis (adjusted odds ratio [AOR], 1.90; 95% CI 1.17-3.09), RPR titer >= 32 (AOR, 1.93; 95% CI, 1.38-2.69), and 3 doses of BPG (AOR, 1.68; 95% CI, 1.20-2.36) were independently associated with a serological response. The time to the first episode of treatment failure was 1184 (standard deviation [SD], 70.5) and 1436 (SD, 80.0) days for 1- and 3-dose group, respectively. Conclusions: Single-dose BPG resulted in a higher serological failure rate and shorter time to treatment failure than 3 weekly doses of BPG in the treatment of early syphilis in HIV-infected patients.

  • 推荐引用方式
    GB/T 7714:
    Yang Chia-Jui,Lee Nan-Yao,Chen Tun-Chieh, et al. One Dose versus Three Weekly Doses of Benzathine Penicillin G for Patients Co-Infected with HIV and Early Syphilis: A Multicenter, Prospective Observational Study [J].PLOS ONE,2014,9(10).
  • APA:
    Yang Chia-Jui,Lee Nan-Yao,Chen Tun-Chieh,Lin Yu-Hui,&Hung Chien-Ching.(2014).One Dose versus Three Weekly Doses of Benzathine Penicillin G for Patients Co-Infected with HIV and Early Syphilis: A Multicenter, Prospective Observational Study .PLOS ONE,9(10).
  • MLA:
    Yang Chia-Jui, et al. "One Dose versus Three Weekly Doses of Benzathine Penicillin G for Patients Co-Infected with HIV and Early Syphilis: A Multicenter, Prospective Observational Study" .PLOS ONE 9,10(2014).
  • 数据来源自科睿唯安Web of Science核心合集
  • 入库时间:
    2021/11/8 20:18:02
  • 更新时间:
    2021/11/8 20:18:02
浏览次数:15 下载次数:0
浏览次数:15
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部